Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class ASSE: 600671

2025 Semi-annual Report

Aug 28, 2025 · Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A via Shanghai Stock Exchange

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment